Dare Bioscience, Inc. Proceeds from Sale of Treasury Stock
Dare Bioscience, Inc. (DARE) reported Proceeds from Sale of Treasury Stock of $10.10 million for the 3-month period ending 2018-03-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfTreasuryStock · last filed 2019-04-01
- Dare Bioscience, Inc. proceeds from sale of treasury stock for the quarter ending 2018-03-31 was $10.10M.
| Period end | Proceeds from Sale of Treasury Stock 3 month |
|---|---|
| 2018-03-31 | $10.10M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |